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Epilepsy is a chronic disorder of the brain 
characterized by recurrent seizures from 
episodic neuronal discharge. Seizures are brief 
episodes of involuntary shaking which may 
involve a part of the body (partial) or the entire 
body (generalized) and sometimes accompanied 
by loss of consciousness (WHO, 2016).There is 
no recognized cause of epilepsy, although it 
may develop following a brain damage caused 
by infection, tumor, trauma or other kinds of 
neurological defects and diseases (Rang et al., 
2007). Over 50 million people have been 
estimated to have epilepsy in the world of 
which about 75% or more are in developing 
countries and underdeveloped countries with 
little or no access to proper medical services 
(Meinardi et al., 2001; Ngugi et al., 2010; WHO 
2016). 
Researchers have continue to search for more 
effective, selective and less toxic antiepileptic 
drugs considering the various challenges 
associated with antiepileptic drugs such as; 
cost, toxicity, side effects, continuous 
medication and poor response to therapy. As 
pharmaceutical researches advance, the need 
for a structure guided pharmacologic activity of 
a compound through the identification of 
pharmacophore is required. Historically, 
pharmacophores were established by Lemont 
Kier, who first mentioned the concept in 1967 
and used the term in his publication (Kier 
1971). The following structural features of an 
anticonvulsant were also proposed: aryl binding 
site responsible for hydrophobic interaction; 
electron donor system (C=N); and most 
importantly a hydrogen bonding area as 
represented by carboxamide CONH2 function 
(Dimmock et al., 1995). 
Unverferth et al. (1998) employed five well 
known but structurally different 
anticonvulsants with sodium channel blockade 
activity carbamazepine, phenytoin, 
lamotrigine, Zonisamide, and Rufinamide to 
propose a 3-point pharmacophore for sodium 
blockade activity. The model comprises an 
electron donor, aryl ring or other hydrophobic 
units and a hydrogen bond acceptor/donor unit. 
Shindikar et al., (2006) proposed a two-point 
pharmacophore, consisting of an aromatic 
center separated from an H-Bonding 
acceptor/donor group within a distance range 
of 4.18-6.88 Ao for anticonvulsants active at the 
sodium channels.  
http://dx.doi.org/10.4314/bajopas.v11i1.55S 
ABSTRACT 
Epilepsy is a disorder of public concern and has been widely treated using various 
pharmacotherapeutic approaches. Despite many breakthrough in its current management, 
there is no one drug that is devoid of shortcomings particularly toxicity and cost. Advances 
in pharmaceutical research have led to the need for a structure guided pharmacologic 
activity of novel compounds. The aim of this study is to evaluate the anticonvulsant activity 
of three (3) novel isomeric forms of 4[(dimethylphenyl) amino]-4-oxobut-2-enoic acid in 
chicks and mice. The 3 isomeric forms i.e. {4-[(2, 4- dimethylphenyl) amino]-4-oxobutenoic 
acid (A), 4-[(2, 5- dimethylphenyl) amino]-4-oxobutenoic acid (B) and 4-[(2, 6- 
dimethylphenyl) amino]-4-oxobutenoic acid (C)} were subjected to acute toxicity studies 
using Lorke’s method of 1983 and anticonvulsant screening using Maximum Electro-Shock 
Test (MEST) and Pentylenetetrazole test (PTZ). The Median lethal doses (LD50) of 
compounds A, B, and C were estimated to be 775, 1131, and 1131 mg/kg respectively. In the 
MEST, compound A (50, 100 and 200 mg/kg) and B (75, 150 and 300 mg/kg) did not show 
protection at all the doses tested, while compound C (75, 150 and 300 mg/kg) showed a 20% 
protection across all the doses tested. In the PTZ, compound A, B and C showed no 
protection. In conclusion, all the 3 isomeric forms of 4[(dimethylphenyl) amino]-4-oxobut-2-
enoic acid though possessed some level of protection but not significant against MEST and 
PTZ models. 
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Figure 1: Distances between the various groups essential for anticonvulsant activity 
 
The dicloro isomeric forms of the compound in 
figure 1 containing 4-[(2, 4- dichlorophenyl) 
amino]-4-oxobutenoic acid, and its 2, 5-
isommeric forms have been synthesized and 
found to have proconvulsive activities 
(Abdullahi, 2013). This could be due to a 
decrease in lipophilicity of the dichloro 
substitute on the aromatic ring thus, reducing 
the ability of the drug to cross the blood-brain 
barrier that is necessary for activity. They 
further suggested that there is a need to 
structurally modify the compounds to a more 
lipophylic state. This led to the replacement of 
the dichloro- substituent with dimethyl 
substituent on the aryl moiety as done in this 
current work. 
This study was aimed at screening for 
anticonvulsant activity of 4-[(2, 4- 
dimethylphenyl) amino]-4-oxobutenoic acid, 4-
[(2, 5- dimethylphenyl) amino]-4-oxobutenoic 
acid and 4-[(2, 6- dimethylphenyl) amino]-4-
oxobutenoic acid in chicks and mice.  
 
MATERIALS AND METHODS 
Chemicals/Drugs 
Compound A {4-[(2, 4- dimethylphenyl) amino]-
4-oxobutenoic acid}, compound B {4-[(2, 5- 
dimethylphenyl) amino]-4-oxobutenoic acid} 
and compound C {4-[(2, 6- dimethylphenyl) 
amino]-4-oxobutenoic acid}, Phenytoin sodium 
(Hospira, UK Limited), Sodium valproate (Sanofi 
Aventis, U.S), Pentylenetetrazole (Sigma 
chemical Co. St Louis, USA), Ethanol and 
Distilled water. 
Laboratory Animals 
Albino mice (20 to 25g) and day old chicks were 
obtained from the Animal House of the 
Department of Pharmacology and Therapeutics, 
Ahmadu Bello University, Zaria and National 
Animal Production and Research Institute 
(NAPRI), Shika, Zaria respectively. The animals 
were maintained in a well-ventilated room, fed 
on standard animal feed and water provided 
adlibitum under standard laboratory conditions 
in accordance with the Ahmadu Bello University 
research policy, ethics and regulation governing 
the care and use of experimental animals. 
Route of Drug Administration 
All treatments were administered 
intraperitoneally (IP) except for 
pentylenetetrazole that was administered 
subcutaneously (SC). Also all solvents used were 
of analytical grades. 
Acute Toxicity Study 
The median lethal dose (LD50) was conducted 
using the method of Lorke, (1983). In the first 
phase, nine (9) mice were divided into three (3) 
groups of three (3) mice each and were treated 
with graded doses of 10, 100 and 1000mg/kg 
body weight each of compound A, B and C. The 
mice were observed for any sign of toxicity and 
death within 24 hours. In the second phase, 
four (4) mice were administered graded doses 
of 1200, 1600, 2900 and 5000 mg/kg body 
weight respectively intraperitoneally with each 
of compound A, B and C. The mice were 
observed for any sign of toxicity and death 
within 24 hours. The LD50 value was calculated 
as the geometric mean of the highest non-
lethal dose and lowest lethal dose. 
Maximal Electroshock-Induced Convulsion 
Test in Chicks 
The method of Swinyard and Kupferberg (1985) 
was employed. Ugobasile electro-convulsive 
machine (model 7801) connected to a stabilizer 
with corneal electrodes placed on the upper 
eyelids of the chicks after dipping them in 
normal saline. A current (80 mA) which induced 
tonic seizures in 90% of the control groups of 
chicks. The shock duration, frequency and 
pulse width was set and maintained at 0.8 sec, 
100 pulse/sec and 0.6 ms respectively were 
used throughout the study. Seizures were 
manifested as hind limb tonic extension (HLTE).  
One hundred and ten (110) day-old chicks were 
randomly divided into eleven (11) groups of ten 
(10) chicks each. Group I were administered 
distilled water (10 ml/kg), group II were 
administered Phenytoin (20 mg/kg), groups III-V 
were administered graded doses of compound A 
(50, 100 and 200 mg/kg) respectively, groups 
VI-VIII were given graded doses of compound B 
(75,150 and 300 mg/kg) respectively and groups 
IX-XI were administered graded doses of 
compound C (75, 150 and 300 mg/kg) 
respectively.  
Thirty minutes later, maximum electroshock 
was administered to induce convulsion in the 
chicks. The ability of the extract to prevent 
this feature or reduce the mean recovery time 
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Pentylenetetrazole (PTZ)-Induced Convulsion 
in Mice 
The method of Swinyard and Goodwill (1989) 
was employed. Fifty five (55) mice were 
divided into eleven (11) groups of five (5) mice 
each. Group I received distilled water (10 
ml/kg), group II received Sodium valproate (200 
mg/kg), groups III-V received graded doses of 
compound A (50, 100, and 200 mg/kg) 
respectively, groups VI-VIII were administered 
graded doses of compound B (75, 150 and 300 
mg/kg) respectively and groups IX-XI were 
given graded doses of compound C (75, 150 and 
300 mg/kg) respectively.  
After 30 minutes, all the groups were 
administered freshly prepared PTZ (100 mg/kg) 
subcutaneously. All the mice were observed for 
a period of 30 minutes after scPTZ. The 
absence of tonic extension of limbs for at least 
5 seconds duration indicates a compound’s 
ability to abolish the effect of PTZ on seizure 
threshold. 
Data Presentation and Analysis 
Data were presented as mean ± standard error 
of mean (SEM) and as percentages in tables and 
figures. Statistical analysis was carried-out 
using One-way ANOVA followed by Dunnett’s 
post hoc test using SPSS software version 23.0. 




Acute Toxicity Studies 
The median lethal doses (LD50) of compound A, B, 
and C were estimated to be 775, 1131, and 1131 
mg/kg respectively. 
 
Table 1: Effect of Compounds A, B and C on Maximal Electroshock Test (MEST)  in Chicks 
Treatments 
(mg/kg) 
Mean Time of 
Recovery  (min) 
Quantal protection Percentage 
protection (%) 
Distilled water (ml/kg)  8.30 ± 0.99 0/10 0.00 





14.70 ± 2.53 
10.20 ± 1.30 














5.90 ± 0.43 
5.20 ± 0.36 














7.7 ± 1.51 
5.80 ± 1.01 









Phenytion 20  2.00 ± 1.37* 8.0/10 80.00 
n=10; Values are presented as Mean ± SEM and percentages. Mean recovery time of seizure compared to normal 
saline group using One way ANOVA followed by Dunnett’s post hoc test; Compound A {4-[(2, 4- dimethylphenyl) 
amino]-4-oxobutenoic acid}, compound B {4-[(2, 5- dimethylphenyl) amino]-4-oxobutenoic acid} and compound C 
{4-[(2, 6- dimethylphenyl) amino]-4-oxobutenoic acid}; * = p < 0.05. 
 
Table 2: Effect of Compounds A, B and C on Pentylenetetrazole (PTZ) - Induced Seizure in Mice 
Treatments  
%(mg/kg)  
Mean Onset of 
seizure (min) 
Quantal Protection Percentage 
protection (%) 
Distilled water 5.40 ± 0.51 0/5 0.00 





8.80 ± 1.07 
8.80 ± 1.71 














5.6 ± 1.63 
6.0 ± 0.89 














10.80 ± 2.10 
4.80 ± 0.66 









Sodium valproate 200 27.00 ± 2.80* 4/5 80.00 
n=5; Values are presented as Mean ± SEM and percentages. Mean onset of seizure compared to normal saline 
group using One way ANOVA followed by Dunnett’s post hoc test; Compound A {4-[(2, 4- dimethylphenyl) amino]-
4-oxobutenoic acid}, compound B {4-[(2, 5- dimethylphenyl) amino]-4-oxobutenoic acid} and compound C {4-[(2, 
6- dimethylphenyl) amino]-4-oxobutenoic acid}; * = p < 0.05. 
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DISCUSSION 
The present study attempts to investigate the 
anticonvulsant potentials of 3 novel synthesized 
compound A {4-[(2, 4- dimethylphenyl) amino]-
4-oxobutenoic acid}, compound B {4-[(2, 5- 
dimethylphenyl) amino]-4-oxobutenoic acid} 
and compound C {4-[(2, 6- dimethylphenyl) 
amino]-4-oxobutenoic acid} in animal models. 
The median Lethal Dose (LD50) obtained for 
compounds A, B and C falls within the range of 
drugs classified as slightly toxic, as all the LD50 
values fall between 500-5000 mg/kg (Hollinger, 
2003; Corbett et al., 1984; Matsumura, 1975). 
During the MEST, there was no significant 
effect of compounds A, B and C on the mean 
recovery time at all the doses tested, indicating 
the inability of the compounds to protect the 
chicks against seizures. While, compound A and 
B did not show any protection against death, 
compound C showed 20% protection against 
death at all the doses tested. Meanwhile, 
Phenytoin which is a standard anticonvulsant 
drug significantly decreased the mean time of 
recovery and produced 80% protection against 
death. In contrast to our study, there was a 
significant decrease in both the onset and mean 
time of recovery for some dichloro- substitutes 
compounds (Abdullahi, 2013).  
MEST is a standard AED test that evaluates the 
testing material’s ability to protect against 
HLTE (DeLorenzo et al., 2001). It is a model for 
generalized tonic clonic seizure, which is highly 
reproducible with a consistent end point. 
Protection against HLTE also indicates the 
ability of a testing material to inhibit or 
prevent seizure discharge within the brainstem 
seizure substrate (Browning, 1992). 
In the present study using PTZ test, there was 
no significant effect of compounds A, B and C 
on the mean onset of seizures at all the doses 
tested, indicating the inability of the 
compounds to protect the chicks against 
seizures. So also, the compounds did not show 
any protection against death at all the doses 
tested. However, sodium valproate, which is a 
standard anticonvulsant drug significantly 
increase the mean onset of seizures and 
produced 80% protection against death. 
Anticonvulsant activity in PTZ test identifies 
compounds that can raise the seizure threshold 
in the brain (Raza et al., 2001). Antiepileptic 
drugs effective in the therapy of generalized 
seizure of petit-mal type exhibit dose 
dependent suppression of PTZ 
induced seizure e.g. phenobarbitone, 
valproate, ethosuximide and benzodiazepines. 
PTZ has been shown to interfere with GABA 
neurotransmitter and the GABAA receptor 
complex (DeDyn et al., 1992). Antagonism of 
PTZ-induced seizure suggests potentiating 
effect on GABAergic neurotransmission. 
 
CONCLUSION 
In conclusion, all the 3 isomeric forms of 
4[(dimethylphenyl) amino]-4-oxobut-2-enoic 
acid though possessed some level of protection 
but did not show significant anticonvulsants 
activity against MEST and PTZ models. Further 
studies using different anticonvulsant models 
are recommended to confirm our findings. 
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